Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Testing and Analysis

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/dta.1860PMID 26360322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48

  2015cited by this paper
• Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.

  2015cited by this paper
• Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.

  2015cited by this paper
• Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens

  2015cited by this paper
• Synthetic cannabimimetic agents metabolized by carboxylesterases.

  2015cited by this paper
• Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.

  2015cited by this paper
• Spice/K2 drugs--more than innocent substitutes for marijuana.

  2014cited by this paper
• Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.

  2014cited by this paper
• An enhanced throughput method for quantification of sulfur mustard adducts to human serum albumin via isotope dilution tandem mass spectrometry.

  2014cited by this paper
• Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22.

  2014cited by this paper
• Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.

  2014cited by this paper
• Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

  2014cited by this paper
• Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

  2014cited by this paper
• Acute kidney injury associated with smoking synthetic cannabinoid

  2014cited by this paper
• Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals

  2014cited by this paper
• A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid

  2014cited by this paper
• K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure

  2013cited by this paper
• URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products.

  2013cited by this paper
• Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product.

  2013cited by this paper
• UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.

  2013cited by this paper
• First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

  2013cited by this paper
• Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

  2013cited by this paper
• First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice.

  2013cited by this paper
• Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety.

  2013cited by this paper
• In Vitro Metabolism and Pharmacokinetic Studies on Methylone

  2013cited by this paper
• Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.

  2013cited by this paper
• The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry.

  2012cited by this paper
• Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

  2012cited by this paper
• Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

  2012cited by this paper
• Designer drugs: a medicinal chemistry perspective

  2012cited by this paper
• In vitro approaches to studying the metabolism of new psychoactive compounds.

  2011cited by this paper
• Identification and quantitation of a benzoylindole (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol-3-yl)-(naphthalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitr

  2011cited by this paper
• Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity

  2011cited by this paper
• Beyond THC: The New Generation of Cannabinoid Designer Drugs

  2011cited by this paper
• Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

  2011cited by this paper
• Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.

  2010cited by this paper
• Detection of JWH-018 metabolites in smoking mixture post-administration urine.

  2010cited by this paper
• Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light

  2010cited by this paper
• Role of Drug Metabolism in Drug Development

  2007cited by this paper
• The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions

  2007cited by this paper
• Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6

  2006cited by this paper
• Lessons from the CYP3A4 promoter.

  2004cited by this paper
• Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor.

  2003cited by this paper
• Metabolism of fluorine-containing drugs.

  2001cited by this paper
• Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.

  1996cited by this paper
• Characterization of the inhibition of P4501A2 by furafylline.

  1994cited by this paper
• Design, synthesis and pharmacology of cannabimimetic indoles

  1994cited by this paper
• Marihuana chemistry.

  1970cited by this paper

• Is UR-144 Synthetic Cannabinoid Toxic to The Neuronal Cells: An In Vitro Evaluation

  2025cites this paper
• The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications.

  2025cites this paper
• Metabolic profiling of a new synthetic cannabinoid receptor agonist, ADMB-FUBIATA, with human liver microsomes, human primary hepatocytes and human recombinant CYP450 enzymes using LC-quadrupole-orbitrap MS.

  2024cites this paper
• Advances in urinary biomarker research of synthetic cannabinoids.

  2023cites this paper
• The Expression Analyses of GSK3B, VEGF, ANG1, and ANG2 in Human Brain Microvascular Endothelial Cells Treated with the Synthetic Cannabinoid XLR-11.

  2023cites this paper
• Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model

  2022cites this paper
• Synthetic Cannabinoid-Related Deaths in England, 2012–2019

  2021cites this paper
• Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models

  2021cites this paper
• Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA

  2021cites this paper
• Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

  2021cites this paper
• The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

  2020cites this paper
• Application of Gas Chromatography–Mass Spectrometry for the Identification and Quantitation of Three Common Synthetic Cannabinoids in Seized Materials from the Jordanian Market

  2020cites this paper
• Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7-azaindole-derived synthetic cannabinoids exemplified using cumyl-5F-P7AICA.

  2020cites this paper
• The key role of mass spectrometry in comprehensive research on new psychoactive substances.

  2020cites this paper
• Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods.

  2019cites this paper
• Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.

  2019cites this paper
• Dark Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice / K2).

  2019cites this paper
• Metabolism of synthetic cannabinoid receptor agonists encountered in clinical casework: major in vivo phase I metabolites of JWH-007, JWH-019, JWH-203, JWH-307, UR-144, XLR-11, AM-2201, MAM-2201 and AM-694 in human urine using LC-MS/MS

  2018influential citation
• Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes

  2018cites this paper
• Metabolic Study of New Psychoactive Substances by Shimpei Watanabe

  2018influential citation
• Pharmakologische Grundlagen: Das Schicksal psychoaktiver Substanzen im menschlichen Körper

  2018cites this paper
• Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy

  2018cites this paper
• Insilco Modeling of Commonly Occurring Genetic Polymorphism of Human CYP3A4 on the Binding Affinity to UR-144

  2017cites this paper
• Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans

  2017cites this paper
• Differences in sociodemographic characteristics, clinical features and serum liver function tests of male cannabis and synthetic cannabinoid users

  2017cites this paper